Ruby F. Meredith

7.6k citations

150 papers · 5.4k indexed · h-index 45

Impact in

Otorhinolaryngology top 0.1%
- Head and Neck Cancer Studies
Radiology, Nuclear Medicine and Imaging top 0.5%
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications

Papers in ⓘ

Otorhinolaryngology 32
- Head and Neck Cancer Studies 32
Radiology, Nuclear Medicine and Imaging 68
- Radiopharmaceutical Chemistry and Applications 52
- Monoclonal and Polyclonal Antibodies Research 23
- Medical Imaging Techniques and Applications 16

Co-authors: Sharon A. Spencer (35 shared papers)Albert F. LoBuglio (38 shared papers)Richard Wheeler (21 shared papers)James A. Bonner (13 shared papers)M.B. Khazaeli (19 shared papers)Sui Shen (22 shared papers)William E. Grizzle (14 shared papers)Jimmy J. Caudell (6 shared papers)
Journals: International Journal of Radiation Oncology*Biology*Physics (42 papers)Cancer Biotherapy and Radiopharmaceuticals (14 papers)Journal of Clinical Oncology (9 papers)Journal of Nuclear Medicine (6 papers)Cancer (5 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Ruby F. Meredith

150 papers receiving 5.3k citations

Peers

Countries citing papers authored by Ruby F. Meredith

Since Specialization

Citations

This map shows the geographic impact of Ruby F. Meredith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby F. Meredith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby F. Meredith more than expected).

Fields of papers citing papers by Ruby F. Meredith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby F. Meredith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby F. Meredith. The network helps show where Ruby F. Meredith may publish in the future.

Co-authors

The 25 scholars most cited alongside Ruby F. Meredith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ruby F. Meredith Line = papers co-authored together Ruby F. Meredith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Phase I Study of Anti–Epidermal Growth Factor Receptor Antibody Cetuximab in Combination With Radiation Therapy in Patients With Advanced Head and Neck Cancer Journal of Clinical Oncology ·Francisco Robert, Mark P. Ezekiel, Sharon A. Spencer, Ruby F. Meredith, James A. Bonner, M.B. Khazaeli, Mansoor N. Saleh, Delicia Carey, Albert F. LoBuglio, Richard Wheeler, Michael R. Cooper, Harlan W. Waksal	2001	377
2	Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck Head & Neck ·Sharon A. Spencer, Jonathan Harris, Richard Wheeler, Mitchell Machtay, Christopher J. Schultz, William J. Spanos, Marvin Rotman, Ruby F. Meredith, Kie‐Kian Ang	2007	246
3	Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Locally Advanced Head-and-Neck Cancer International Journal of Radiation OncologyBiologyPhysics ·Jimmy J. Caudell, Philip E. Schaner, Ruby F. Meredith, Julie L. Locher, Lisle M. Nabell, William R. Carroll, J. Scott Magnuson, Sharon A. Spencer, James A. Bonner	2008	245
4	MIRD Pamphlet No. 24: Guidelines for Quantitative ¹³¹I SPECT in Dosimetry Applications Journal of Nuclear Medicine ·Yuni K. Dewaraja, Michael Ljungberg, Alan J. Green, Pat Zanzonico, Eric C. Frey, Wesley E. Bolch, A.B. Brill, Mark Dunphy, Darrell R. Fisher, Roger W. Howell, Ruby F. Meredith, George Sgouros, Barry W. Wessels	2013	223
5	Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers. PubMed ·James A. Bonner, Kevin P. Raisch, Hoa Q. Trummell, Francisco Robert, Ruby F. Meredith, Sharon A. Spencer, Donald J. Buchsbaum, Mansoor N. Saleh, Murray Stackhouse, Albert F. LoBuglio, Glenn E. Peters, William R. Carroll, Harlan W. Waksal	2000	175
6	Dosimetric Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Squamous Cell Carcinoma of the Head and Neck International Journal of Radiation OncologyBiologyPhysics ·Jimmy J. Caudell, Philip E. Schaner, Renée A. Desmond, Ruby F. Meredith, Sharon A. Spencer, James A. Bonner	2009	171
7	Intraperitoneal Radioimmunotherapy of Ovarian Cancer with177Lu-CC49: A Phase I/II Study Gynecologic Oncology ·Ronald D. Alvarez, Edward E. Partridge, M.B. Khazaeli, Gene Plott, M. E. Austin, Larry C. Kilgore, Charles D. Russell, Tiepu Liu, William E. Grizzle, Jeffrey Schlom, Albert F. LoBuglio, Ruby F. Meredith	1997	144
8	RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck International Journal of Radiation OncologyBiologyPhysics ·Sharon A. Spencer, Jonathan Harris, Richard Wheeler, Mitchell Machtay, Christopher J. Schultz, William J. Spanos, Marvin Rotman, Ruby F. Meredith	2001	142
9	MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response—Implications for Radionuclide Therapy Journal of Nuclear Medicine ·Barry W. Wessels, Mark Konijnenberg, Roger Dale, Hazel B. Breitz, Marta Cremonesi, Ruby F. Meredith, Alan J. Green, Lionel G. Bouchet, A.B. Brill, Wesley E. Bolch, George Sgouros, Stephen R. Thomas	2008	130
10	Combined Modality Therapy of A431 Human Epidermoid Cancer Using Anti-EGFr Antibody C225 and Radiation Cancer Biotherapy and Radiopharmaceuticals ·Mansoor N. Saleh, Kevin P. Raisch, Murray Stackhouse, William E. Grizzle, James A. Bonner, Matthew S. Mayo, Hyung‐Gyoon Kim, Ruby F. Meredith, Richard Wheeler, Donald J. Buchsbaum	1999	128
11	Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma Blood ·Andres Forero, Paul L. Weiden, Julie M. Vose, Susan J. Knox, Albert F. LoBuglio, Jordan Hankins, Michael L. Goris, Vincent J. Picozzi, Don B. Axworthy, Hazel B. Breitz, Robert B. Sims, Richard Ghalie, Sui Shen, Ruby F. Meredith	2004	117
12	Pharmacokinetics and Imaging of ²¹² Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer Patients Cancer Biotherapy and Radiopharmaceuticals ·Ruby F. Meredith, Julien Torgue, Michael Azure, Sui Shen, Souheil Saddekni, Eileen Banaga, R. Carlise, Patty Bunch, Daniel Yoder, Ronald D. Alvarez	2013	107
13	Mucositis-Related Morbidity and Resource Utilization in Head and Neck Cancer Patients Receiving Radiation Therapy With or Without Chemotherapy Journal of Pain and Symptom Management ·Barbara A. Murphy, Jennifer L. Beaumont, John J. Isitt, Adam S. Garden, Clement K. Gwede, Andy Trotti, Ruby F. Meredith, Joel B. Epstein, Quynh‐Thu Le, David M. Brizel, Lisa A. Bellm, Nancy Wells, David Cella	2009	106
14	Dose Escalation and Dosimetry of First-in-Human α Radioimmunotherapy with ²¹²Pb-TCMC-Trastuzumab Journal of Nuclear Medicine ·Ruby F. Meredith, Julien Torgue, Sui Shen, Darrell R. Fisher, Eileen Banaga, Patty Bunch, Desiree E. Morgan, Jinda Fan, J. Michael Straughn	2014	104
15	Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans. PubMed ·M.B. Khazaeli, Mansoor N. Saleh, T.-P. Liu, Ruby F. Meredith, Richard Wheeler, Terry Baker, David J. King, David S. Secher, Laquetta Allen, Kim R. Rogers	1991	98
16	Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49. PubMed ·Ruby F. Meredith, Anton J. Bueschen, M.B. Khazaeli, Walter E. Plott, William E. Grizzle, Richard Wheeler, Jeffrey Schlom, Charles D. Russell, Tiepu Liu, Albert F. LoBuglio	1994	97
17	A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancer. PubMed ·Ronald D. Alvarez, Warner K. Huh, M.B. Khazaeli, Ruby F. Meredith, Edward E. Partridge, Larry C. Kilgore, William E. Grizzle, Sui Shen, J.Max Austin, Mack N. Barnes, Delicia Carey, Jeffrey Schlom, Albert F. LoBuglio	2002	89
18	Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab American Journal of Clinical Oncology ·Ruby F. Meredith, Julien Torgue, Tania A. Rozgaja, Eileen Banaga, Patty Bunch, Ronald D. Alvarez, J. Michael Straughn, M.C. Dobelbower, Andrew M. Lowy	2016	85
19	Rationales, evidence, and design considerations for fractionated radioimmunotherapy Cancer ·Gerald L. DeNardo, J Schlom, Donald J. Buchsbaum, Ruby F. Meredith, Joseph A. O’Donoghue, George Sgouros, John L. Humm, Sally J. DeNardo	2002	84
20	Longitudinal evaluation of the oral mucositis weekly questionnaire‐head and neck cancer, a patient‐reported outcomes questionnaire Cancer ·Joel B. Epstein, Jennifer L. Beaumont, Clement K. Gwede, Barbara A. Murphy, Adam S. Garden, Ruby F. Meredith, Quynh‐Thu Le, David M. Brizel, John J. Isitt, David Cella	2007	81

About Ruby F. Meredith

Ruby F. Meredith is a scholar working on Otorhinolaryngology, Radiology, Nuclear Medicine and Imaging, Radiation, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 150 papers that have together received 5.4k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (52 papers), Head and Neck Cancer Studies (32 papers), Lymphoma Diagnosis and Treatment (29 papers), Monoclonal and Polyclonal Antibodies Research (23 papers), Lung Cancer Treatments and Mutations (22 papers), Oral health in cancer treatment (18 papers), Advanced Radiotherapy Techniques (17 papers) and Medical Imaging Techniques and Applications (16 papers). The work is most often cited by research in Otorhinolaryngology (1.5k citations), Radiology, Nuclear Medicine and Imaging (2.5k citations), Radiation (577 citations), Pulmonary and Respiratory Medicine (2.1k citations) and Oncology (1.7k citations). Ruby F. Meredith has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Sharon A. Spencer, Albert F. LoBuglio, Richard Wheeler, James A. Bonner, M.B. Khazaeli, Sui Shen, William E. Grizzle, Jimmy J. Caudell, Donald J. Buchsbaum and Susan J. Knox. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Cancer Biotherapy and Radiopharmaceuticals, Journal of Clinical Oncology, Journal of Nuclear Medicine and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact